SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Sharck Soup -- Ignore unavailable to you. Want to Upgrade?

To: Wes Stevens who wrote (35673)9/18/2001 11:18:00 AM
From: Dr. Voodoo  Read Replies (2) | Respond to of 37746
 
With respect to valuation, yes, they are probably overvalued with respect to other sectors. But, the fact is a lot of biotechs aren't going to be a tax loss because they have gone up in a down market--no reason to sell now.

Thus, if we are at a bottom in the markets, they may not go down much further.

V


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News